LabCompass

Weidong Xiao

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Established · publishing since 1997
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in InsectsCRISPR and Genetic EngineeringRNA Interference and Gene DeliveryCAR-T cell therapy research

Publications

182

Citations

6,023

Est. group size

—

Recurring co-author estimate

Active years

29

Publishing since 1997

Research summary
AI-generated

Weidong Xiao works in molecular biology and gene therapy, with a focus on adeno-associated virus (AAV) vectors used to deliver genes into cells. A recurring theme is treating blood disorders such as hemophilia A, including studying why some patients develop immune responses (inhibitors) against clotting factor therapies. The publication record also spans a broad range of collaborative work in cancer immunotherapy and other biomedical topics.

Adeno-associated virus (AAV) gene therapy vectorsHemophilia A and clotting factor immunogenicityGene delivery and genetic engineeringCancer immunotherapyMolecular and bioinformatic analysis of viral genomes

Publication activity has been steady over the past decade, averaging around 9-12 papers per year with a peak in 2023.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

Current awards run through January 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.

  • ActiveNIH P01HL160472through Jan 2027 · $472k awarded

    Biology of Subgenomic AAV Vector Particles

2 earlier awards
  • NIH U54HL142019May 2018 – Apr 2024 · $271k awarded

    Project-005

  • NIH R01HL130871Jan 2016 – Dec 2021 · $481k awarded

    Development of highly efficient factor VIII mini-gene therapy

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 1,724 established Biochemistry, Genetics and Molecular Biology PIs within our index
Citations: 6,023cohort median 3,385
h-index: 38cohort median 27
Publications / year (recent): 9.2cohort median 4.6

Typically publishes in teams of ~9 · 9% small-team papers (≤3 authors) · across 62 venues

Publication cadence
Publications per year over the last 10 years — averaging 9.2/year recently
2017: 7 publications172018: 11 publications182019: 8 publications192020: 11 publications202021: 12 publications212022: 11 publications222023: 18 publications18232024: 6 publications242025: 11 publications2526
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 5 collaborators at the same institution2023: 9 collaborators at the same institution2024: 0 collaborators at the same institution2025: 1 collaborator at the same institution1719212325
Recent publications
Publishes in
  • Molecular Therapy — Methods & Clinical Development×9
  • Molecular Therapy×5
  • Human Gene Therapy×4
  • Blood×4
  • UNC Libraries×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile